Every material Form 8-K Scienture Holdings, Inc. has filed with the SEC since September 14, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Scienture Holdings reported preliminary, unaudited revenue of about $1.22 million for the quarter ended September 30, 2026, up 256% from about $344,000 in the second quarter, driven by the August 2026 REZENOPY launch and continued Arbli sales growth. The company also regained compliance with Nasdaq's $1.00 minimum bid price requirement, and Nasdaq closed the matter, so its common stock will remain listed. The filing does not report profit or earnings per share for the quarter.
Preliminary unaudited Q3 2026 revenue of about $1.22 million, versus about $344,000 in Q2 2026 (up 256%).
Arbli wholesale unit sales rose 74% sequentially; REZENOPY launched in August 2026 with initial wholesale shipments.
On October 19, 2026, Nasdaq confirmed the stock closed at or above $1.00 for ten consecutive trading days, and the matter is closed.
Scienture Holdings, Inc. (Nasdaq: SCNX) effected a 1-for-25 reverse stock split at 12:01 a.m. Eastern Time on October 5, 2026, after its board approved the split on September 17, 2026. The company said the split is intended to help it regain compliance with Nasdaq's $1.00 minimum bid price rule. Shareholders' proportional ownership is stated to remain virtually unchanged, but the number of shares outstanding falls sharply.
Split ratio: 1-for-25, so every 25 shares became one share; the company expects about 1,642,565 shares outstanding after the split, down from 41,064,146 as of September 30, 2026.
Reason given: to regain compliance with Nasdaq's continued listing rule requiring a minimum bid price of at least $1.00 per share.
Fractional shares were not issued; holders entitled to fractions receive a cash payment in lieu.
Trading symbol remains SCNX under a new CUSIP, 80880X203 (the 8-K states 8088X203 in one place).
On September 14, 2026, Scienture Holdings posted a revised investor presentation to its website and filed it as Exhibit 99.1 to a Form 8-K. The company said it intends to use the presentation in meetings with analysts and potential investors. The filing contains no financial results, guidance, or new financial figures, and the presentation speaks only as of the filing date.
The revised investor presentation was posted to the company's website on September 14, 2026 and is attached as Exhibit 99.1.
The company will use the presentation at various meetings with analysts, potential investors, and other interested parties.
The company disclaims any obligation to update the presentation and says it should be read with its SEC filings, including its Form 10-K for the year ending December 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Scienture Holdings, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →